Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received suspension orders for drug licenses at two stores in Nagpur, Maharashtra. The store at Santaji ward Warthi Road faces a forty-day suspension, while the store at Takiya ward, Bhandadara, will be suspended for forty-five days. This action, resulting from violations of the Drugs and Cosmetics Act, may lead to a potential revenue loss of approximately ₹9.72 crore (cr) and ₹20.48 crore (cr) for the respective stores. Investors should monitor the impact of this operational disruption on MedPlus's financial performance closely.